HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 2,400 shares, a decline of 84.1% from the November 15th total of 15,100 shares. Based on an average daily trading volume, of 24,500 shares, the short-interest ratio is presently 0.1 days.
HAVN Life Sciences Price Performance
HAVLF stock remained flat at $0.05 during midday trading on Tuesday. 4,300 shares of the company's stock were exchanged, compared to its average volume of 5,588. HAVN Life Sciences has a 1 year low of $0.05 and a 1 year high of $4.77. The stock's fifty day simple moving average is $0.07 and its 200-day simple moving average is $0.59.
Get HAVN Life Sciences alerts:About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Further Reading
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
- Mullen Automotive Shifts Into Higher Gear
- Why the Cracker Barrel Selloff Looks Overcooked
- It's Still Too Soon to Shop for Kohl's Stock
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.